Items where Author is "Goekbuget, N."

Article

Goekbuget, N. and Topp, M. S. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H. and Reichle, A. and Marks, R. and Brueggemann, M. and Ritgen, M. and Klappers, P. and Mergen, N. and Goebeler, M. E. and Einsele, H. and Hoelzer, D. and Bargou, R. (2012) ANTI-CD19 BITE BLINATUMOMAB INDUCES HIGH COMPLETE REMISSION RATE IN ADULT PATIENTS WITH RELAPSED B-PRECURSOR ALL: UPDATED RESULTS OF AN ONGOING PHASE II TRIAL. ANNALS OF ONCOLOGY, 23 (Suppl1). i20-i21. ISSN 0923-7534

Topp, M. and Goekbuget, N. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H-A and Reichle, A. and Marks, R. and Brueggemann, M. and Ritgen, M. and Klappers, P. and Mergen, N. and Goebeler, M-E and Einsele, H. and Hoelzer, D. and Bargou, R. (2012) Anti-CD19 BiTE blinatumomab induces high complete remission rate and prolongs overall survival in adult patients with relapsed/refractory B-precursor ALL. ONKOLOGIE, 35 (suppl6). p. 186. ISSN 0378-584X

Topp, M. S. and Goekbuget, N. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H. -A and Reichle, A. and Marks, R. and Klappers, P. and Mergen, N. and Nagorsen, D. and Kufer, P. and Goebeler, M. -E and Einsele, H. and Hoelzer, D. and Bargou, R. (2011) Clinical activity of the anti-CD19 bite (R) blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL): Interim results of a phase II study. ONKOLOGIE, 34 (Suppl6). p. 16. ISSN 0378-584X

Other

Pfeifer, H. and Cayuela, J. -M. and Spiekermann, K. and Beck, J. and Jung, W. and Viardot, A. and Schaefer-Eckhart, K. and Reichle, A. and Maury, S. and Schmitz, N. and Heidenreich, D. and Panse, J. and Junghanss, C. and Raffoux, E. and Suarez, F. and Guillerm, G. and Alexis, M. and Lissandre, S. and Huguet, F. and Isnard, F. and Lepetre, S. and Escofffre-Barbe, M. and Ribera, J. -M. and Goekbuget, N. and Dombret, H. and Hoelzer, D. and Rousselot, P. and Ottmann, O. (2015) European working group for adult ALL phase II trial of nilotinib in combination with chemotherapy for first-line treatment in elderly patients with de novo Philadelphiachromosome positive acute lymphoblastic leukemia (EWALL-PH-02). KARGER, BASEL.

Pfeifer, H. and Rousselot, P. and Cayuela, J. M. and Karsten, S. and Beck, J. and Jung, W. E. and Viardot, A. and Schaefer-Eckart, K. and Reichle, A. and Maury, S. and Schmitz, N. and Heidenreich, D. and Panse, J. and Junghanss, C. and Raffoux, E. and Suarez, F. and Guillerm, G. and Alexis, M. and Lissandre, S. and Huguet, F. and Isnard, F. and Lepretre, S. and Escoffre-Barbe, M. and Ribera, J. M. and Goekbuget, N. and Hoelzer, D. and Dombret, H. and Ottmann, O. G. (2015) NILOTINIB IN COMBINATION WITH CHEMOTHERAPY FOR FIRST-LINE TREATMENT IN ELDERLY PATIENTS WITH PHILADELPHIA-POSITIVE ALL: RESULTS OF THE EUROPEAN WORKING GROUP FOR ADULT ALL(EWALL-PH-02). FERRATA STORTI FOUNDATION, PAVIA.

Topp, M. S. and Goebeler, M-E and Einsele, H. and Bargou, R. and Goekbuget, N. and Zugmaier, G. and Mergen, N. and Klappers, P. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H. A. and Bruegge-mann, M. and Ritgen, M. and Reichle, A. and Marks, R. and Faul, C. (2013) ANTI-CD19 BITE (R) BLINATUMOMAB INDUCES HIGH COMPLETE REMISSION RATE AND LONG OVERALL SURVIVAL IN ADULT PATIENTS WITH RELAPSED/REFRACTORY B-PRECURSOR ALL. SPRINGER, NEW YORK.

Topp, M. and Goekbuget, N. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H. A. and Reichle, A. and Marks, R. and Faul, C. and Brueggemann, M. and Ritgen, M. and Klappers, P. and Mergen, N. and Goebeler, M. -E. and Einsele, H. and Hoelzer, D. and Bargou, R. (2013) Anti-CD19 BiTE (R) blinatumomab induces high complete remission rates in adult patients with relapsed/refractory B-precursor acute lymphoblastic leukaemia (ALL) including relapse after stem cell transplantation (SCT). NATURE PUBLISHING GROUP, LONDON.